icon.article.dark Industry news COVID-19 research for children Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced its role as a Data Coordinating Center on a team whose work has accelerated pediatric COVID-19 research through the Pharmacokinetics, Read more icon.arrow--dark
icon.article.dark Industry news Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19 Emmes today announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID-19 Treatment Trial (ACTT-3), using its proprietary Advantage eClinical system. The ACTT-3 trial assessed the efficacy and safety of interferon beta-1a plus Read more icon.arrow--dark
icon.article.dark Industry news Vaccine Passports in NHS app unethical say FarmaTrust Blockchain, not the NHS app, is the obvious overlooked answer to security and custodianship Read more icon.arrow--dark
